Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Urol. 2016 Feb 19;196(2):473–477. doi: 10.1016/j.juro.2016.02.076

Table 2.

Prevalence of co-occurrent disease in relation to prevalent overactive bladder.

Overactive bladder
No Yes
n/ N (%) n/ N (%)
Bechterew’s disease 48/9998 (0.5) 8/879 (0.9)
Systemic lupus erymatosus 16/10000 (0.2) 2/882 (0.2)
Struma 235/9996 (2.3) 29/882 (3.3)
Gland disorder, excl. struma 163/10002 (1.6) 13/880 (1.5)
Migraine 2787/9958 (28.0) 296/878 (33.7)
Crohn’s disease 43/9998 (0.4) 2/879 (0.2)
Ulcerative colitis 77/9987 (0.8) 9/877 (1.0)
Eating disorder 831/9999 (8.3) 107/878 (12.2)
Chronic fatigue 1009/10743 (9.4) 162/983 (16.5)
Rheumatism 66/10667 (0.6) 10/967 (1.0)
Fibromyalgia 1382/10430 (13.3) 205/941 (21.8)
Asthma 919/8718 (10.5) 48/393 (12.2)
Eczema 2550/10534 (24.2) 257/944 (27.2)
Hay fever 1832/10506 (17.4) 178/941 (18.9)
Diabetes 100/10018 (1.0) 14/880 (1.6)
Heart attack 3/4364 (0.1) 1/396 (0.3)
Urinary tract infection 4946/11520 (42.9) 560/1023 (54.7)
Dysmenorrhea 3521/10756 (32.7) 386/906 (42.6)
Pelvic pain 1026/10676 (9.6) 131/897 (14.6)
Endometriosis 390/10887 (3.6) 42/921 (4.6)
Sexually transmitted disease 2050/9690 (21.2) 219/909 (24.1)